RxDoctor Payments Data

Ryan Welborn, DO

Family Medicine · Greensboro, NCNPI 1942829965

Payments from drug & device makers

$1,735in general payments, 2019–2025

Across 99 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$291
  • Lilly USA, LLC$275
  • Novo Nordisk$223
  • Pfizer$200
  • GSK$140
  • Gilead$114
  • plus $492 from 15 others

What the payments were for

  • Food & beverage$1,735100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,735 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$98,671
Medicare patients
179
Services billed
1,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin42$47,176
EliquisApixaban41$42,470
RybelsusSemaglutide25$35,937
OzempicSemaglutide35$32,486
MounjaroTirzepatide25$26,970
Lagevrio (Eua)Molnupiravir11$6,698
PaxlovidNirmatrelvir/Ritonavir14$5,476
ShingrixVaricella-Zoster Ge/As01b/Pf23$5,254
Boostrix TdapDiphth,pertuss(Acell),tet Vac66$4,592
SymbicortBudesonide/Formoterol Fumarate17$4,342
Arnuity ElliptaFluticasone Furoate16$3,982
Rosuvastatin Calcium325$3,635
Atorvastatin Calcium313$3,337
Varenicline Tartrate15$2,647
Amlodipine Besylate317$2,195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$223$68,42360 claims
PfizerEliquis, Paxlovid$200$47,94655 claims
Boehringer IngelheimJardiance$60$47,17642 claims
Lilly USA, LLCMounjaro$275$26,97025 claims
GSKShingrix, Arnuity Ellipta$140$9,23639 claims
MerckLagevrio (Eua)$30$6,69811 claims
AstraZenecaSymbicort$114$4,34217 claims
AbbVieSynthroid$38$96511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →